The The effect of temperature on peracetic acid efficiency in fungal elimination in reused dialyzer The effect of temperature on peracetic acid efficiency in fungal elimination in reused dialyzer

Main Article Content

suwadee phowichit

Abstract

Introduction: Peracetic acid (PAA) decomposition upon dialyzer reprocessing has a direct relationship with the rising global temperature. Purpose: The current objective is to investigate the 0.16 %PAA performance for disruption of Candida albicans and Aspergillus niger in dialyzer undergoing the increase of temperature 35-50 Celsius (°C) and duration of incubations 0-96 hour (h). Material and methods: The twenty dialyzers were randomly assigned to 1.1) C. albicans-inoculated in control group of dialyzer, 1.2) C. albicans-inoculated in sample group of dialyzer received PAA 2.1) A. niger-inoculated in control group of dialyzer 2.2) A. niger-inoculated in sample group of dialyzer received PAA. Then, a residual concentration of PAA in sample group of dialyzers were quantified with peracetic acid test strip. Result: At 35, 40, and 45 °C, the sample group number 1.2) and 2.2) showed that PAA started decomposing for 48 h. Amount of PAA residues for 96 h gradually decreased from 2,000 parts per million (ppm) to 1,500 ppm at 35 °C and decreased dramatically with contents of 1,000 ppm at 40 and 45°C. The highest rate of PAA degradation was found at 50 °C with a rapid decline from 1500 ppm at 24 h and 800 ppm at 96 h. Although PAA decay associated with rising temperatures, both sample groups still showed strong antiproliferation of both fungi, suggesting that PAA remains enough disinfectant. Conclusion: A limitation of PAA in using dialyzer reuse for high-temperature must contain a minimum level both before and after reprocessing procedure as 2,000 ppm and 800 ppm, respectively.          

Article Details

Section
นิพนธ์ต้นฉบับ (Original Article)

References

1.AAMI. Recommended practice for reused of hemodilayzer.. Vergenia: Association for advancement of medical instrumentation publisher; 2008.
2.Kitis M. Disinfection of wastewater with peracetic acid: a review. Environ Int 2004;30:47- 55.
3.Canavese C, Petrarulo M, Massarenti P, Berutti S, Fenoglio R, Pauletto D, et al. Long term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 2005;45:540-9.
4.Kunigk L GD, Forte F, Vidal KP, Gomes LF, Sousa PF. The influence of temperature on the decomposition kinetics of peracetic acid in solutions. Braz J Chem Eng 2001;18:217-20.
5.Phowichit S, Ussawawongaraya W, Phusantisampan T, Spilles N, Rattanawong W. The influence of temperature on peracetic acid efficiency in dialyzer reuse. JNST 2017;23:52-7
6.Babic MN G-CN, Vargha M, Tischner Z, Magyar D, Veríssimo C, Sabino R, et al. Fungal Contaminants in Drinking Water Regulation? A Tale of Ecology, Exposure, Purification and Clinical Relevance. Int J Environ Res Public Health 2017;14:1-44.
7.Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004;10 (Suppl 1):48-66.
8.Garcia-Rubio R, de Oliveira HC, Rivera J, Trevijano-Contador N. The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species. Front Microbiol.2019;10:1-13.
9.Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002;8:881-90.
10.I.L. P. Biotic Characteristics of the Environment. Edition T, editor: Academic Press; 2019. 61-87 p.
11.R YBaR. Emerging Pathogens of the Candida Species: IntechOpen; 2018.
12.Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence 2013;4:119-28.
13.Eguia A, Arakistain A, De-la-Pinta I, Lopez-Vicente J, Sevillano E, Quindos G, et al. Candida albicans biofilms on different materials for manufacturing implant abutments and prostheses. Med Oral Patol Oral Cir Bucal 2020;25:e13-20.
14.Chen S, Tsoi JKH, Tsang PCS, Park YJ, Song HJ, Matinlinna JP. Candida albicans aspects of binary titanium alloys for biomedical applications. Regen Biomater 2020;7:213-20.
15.Brunetti G, Navazio AS, Giuliani A, Giordano A, Proli EM, Antonelli G, et al. Candida blood stream infections observed between 2011 and 2016 in a large Italian University Hospital: A time-based retrospective analysis on epidemiology, biofilm production, antifungal agents consumption and drug-susceptibility. PLoS One 2019;14:1-17.
16.Vargas-Blanco D, Lynn A, Rosch J, Noreldin R, Salerni A, Lambert C, et al. A pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans. Ann Clin Microbiol Antimicrob 2017;16:41.
17.Surapuram V, Setzer WN, McFeeters RL, McFeeters H. Antifungal activity of plant extracts against Aspergillus niger and Rhizopus stolonifer. Nat Prod Commun 2014;9:1603-5.
18.Person AK, Chudgar SM, Norton BL, Tong BC, Stout JE. Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis. J Med Microbiol 2010;59):834-8.
19.Lin L, Zhao CH, Yin XY, Chen YL, Zhai HY, Xu CW, et al. Aspergillus niger bloodstream infection in gastric cancer after common hepatic artery embolization: A case report. Exp Ther Med 2017;14:1427-32.
20.Salim NL, Azhany Y, Abdul Rahman Z, Yusof R, Liza-Sharmini AT. Infected Baerveldt Glaucoma Drainage Device by Aspergillus niger. Case Rep Ophthalmol Med 2015;2015:1-3.
21.Arvanitidou M, Spaia S, Velegraki A, Pazarloglou M, Kanetidis D, Pangidis P, et al. High level of recovery of fungi from water and dialysate in haemodialysis units. J Hosp Infect 2000;45:225-30.
22.Figel IC, Marangoni PR, Tralamazza SM, Vicente VA, Dalzoto Pdo R, do Nascimento MM, et al. Black yeasts-like fungi isolated from dialysis water in hemodialysis units. Mycopathologia 2013;175:413-20.
23.Cai M, Sun P, Zhang L, Huang CH. UV/Peracetic Acid for Degradation of Pharmaceuticals and Reactive Species Evaluation. Environ Sci Technol 2017;51:14217-24.
24.Leypoldt JK MB, Pereira BJ, Levin NW, Petersen J, Jani A. Does reuse have clinically important effects on dialyzer function? Semin Dial 2000;13:281-90.
25.Bond TC NA, Krishnan M, Wilson SM, Mayne T. Dialyzer reuse with peracetic acid does not impact patient mortality. Clin J Am Soc Nephtol 2011;6:1368-74.
26.Nadeem SG SA, Hakim ST, Anjum Y, Kazm SU. Effect of growth media, pH and temperature on yeast to hyphal transition in Candica albicans. J Med Microbiol 2013;3:185-92.
27.DJ RWaW. Disinfection of endoscope: review of new chemical sterilants used for high-level disinfection. . Infect Control Hosp Epideminol 1999;20:69-76.
28.Bradley CR, Babb JR, Ayliffe GA. Evaluation of the Steris System 1 Peracetic Acid Endoscope Processor. J Hosp Infect 1995;29:143-51.
29.Products As. Cidex PA–Peracetic acid solution. Irvine 1998;CA (ASP):1-9.
30.Inupakutika MA, Sengupta S, Devireddy AR, Azad RK, Mittler R. The evolution of reactive oxygen species metabolism. J Exp Bot 2016;67:5933-43.
31.J de Andrade Junior DR, de Souza RB, dos Santos SA, de Andrade DR. Oxygen free radicals and pulmonary disease. J Bras Pneumol 2005; 31:60-8.
32.Palacios-CabreraI H, Taniwaki MH, Hashimoto JM, de Menezes HC. Growth of Aspergillus ochraceus, A. carbonarius and A. niger on culture media at different water activities and temperatures. Braz J Microbiol 2005;36:24-8.